Form 6K Inventiva Sa For: 12 June
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Inventiva SA (IVAA)
Inventiva SA stock price live, this page displays EPA IVAA stock exchange data. View the IVAA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Inventiva SA real time stock price chart below.
What Is the Inventiva SA Stock Price Today?
The Inventiva SA stock price today is 3.43.
What Is the Stock Symbol for Inventiva SA?
The stock symbol for Inventiva SA is "IVAA."
What Stock Exchange Does Inventiva SA Trade On?
Inventiva SA is listed and trades on the Paris stock exchange.
Is Inventiva SA a Good Stock to Buy?
Determining whether Inventiva SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IVAA quote. (ISIN: FR0013233012)
What Is the Inventiva SA Stock Price Today?
The Inventiva SA stock price today is 3.43.
What Is the Stock Symbol for Inventiva SA?
The stock symbol for Inventiva SA is "IVAA."
What Stock Exchange Does Inventiva SA Trade On?
Inventiva SA is listed and trades on the Paris stock exchange.
Is Inventiva SA a Good Stock to Buy?
Determining whether Inventiva SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IVAA quote. (ISIN: FR0013233012)
3.43
+0.15(+4.58%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.28
3.48
52 wk Range
2.62
6.20
IVAA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.283.48
52 wk Range
2.626.20
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IVAA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
9.63
Upside
+180.89%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
- Form 6K Inventiva S.A. For: 22 May
- Investing.com
- Form 6K Inventiva S.A. For: 12 June
- Investing.com
- Form 13G Inventiva S.A. For: 15 May
- Investing.com
- Form 6K Inventiva Sa For: 9 June
- Investing.com
- Form 6K Inventiva Sa For: 12 June
- Investing.com
- Form 6K Inventiva S.A. For: 12 June
- Investing.com
- Form 6K Inventiva Sa For: 9 June
- Investing.com
- Form 6K Inventiva S.A. For: 3 June
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 9.63
(+180.89% Upside)
Earnings
Latest Release
May 26, 2026
EPS / Forecast
-0.20 / -0.23
Revenue / Forecast
-- / --
Compare IVAA to Peers and Sector
Metrics to compare | IVAA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIVAAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.3x | −2.6x | −0.4x | |
PEG Ratio | −0.06 | 0.00 | 0.00 | |
Price/Book | −28.0x | 0.9x | 2.6x | |
Price / LTM Sales | 118.1x | 10.4x | 3.0x | |
Upside (Analyst Target) | 174.4% | 210.6% | 50.7% | |
Fair Value Upside | Unlock | −1.1% | 6.5% | Unlock |
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. The company also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. Inventiva S.A. was incorporated in 2011 and is headquartered in Daix, France.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Inventiva (IVAA) Stock Price Today?
The Inventiva stock price today is 3.43 EUR.
What Stock Exchange Does Inventiva Trade On?
Inventiva is listed and trades on the Paris Stock Exchange.
What Is the Stock Symbol for Inventiva?
The stock symbol for Inventiva is "IVAA."
What Is the Inventiva Market Cap?
As of today, Inventiva market cap is 810.44M EUR.
What Is Inventiva's Earnings Per Share (TTM)?
The Inventiva EPS (TTM) is -1.90.
When Is the Next Inventiva Earnings Date?
Inventiva will release its next earnings report on Sep 25, 2026.
From a Technical Analysis Perspective, Is IVAA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Inventiva Stock Split?
Inventiva has split 0 times.
How Many Employees Does Inventiva Have?
Inventiva has 73 employees.
What is the current trading status of Inventiva (IVAA)?
As of Jul 03, 2026, Inventiva (IVAA) is trading at a price of 3.43 EUR, with a previous close of 3.28 EUR. The stock has fluctuated within a day range of 3.28 EUR to 3.48 EUR, while its 52-week range spans from 2.62 EUR to 6.20 EUR.
What Is Inventiva (IVAA) Price Target According to Analysts?
The average 12-month price target for Inventiva is 9.63 EUR, with a high estimate of 15.372 EUR and a low estimate of 7 EUR. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +180.89% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.